Immunotherapy for tuberculosis: wave of the future or tilting at windmills?
Barnes
Peter F
PF
D000995:Antitubercular Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000276:immunology; D018088:Tuberculosis, Multidrug-Resistant / Q000628:therapy; D014397:Tuberculosis, Pulmonary / Q000276:immunology / Q000628:therapy*
D000995:Antitubercular Agents; D007376:Interleukin-2